FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

N Malenkovich

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Lymphocyte Activation

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Yvette E Latchman; Clive R Wood; Tatyana Chernova; Divya Chaudhary; M Borde; Irina Chernova; Yoshiko Iwai; AJ Long; Julia A Brown; R Nunes; Edward Greenfield; K Bourque; Vassiliki A Boussiotis; Laura L Carter; Beatriz M Carreno; N Malenkovich; H Nishimura; T Okazaki; Tasuku Honjo; Arlene H Sharpe; Gordon J Freeman
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Alexander J McAdam; Rebecca J Greenwald; M A Levin; Tatyana Chernova; N Malenkovich; Vincent Ling; Gordon J Freeman; Arlene H Sharpe
ICOS is critical for CD40-mediated antibody class switching.
Alexander J McAdam; Tammy T Chang; A E Lumelsky; Edward Greenfield; Vassiliki A Boussiotis; Jonathan S Duke-Cohan; Tatyana Chernova; N Malenkovich; Claudia Jabs; Vijay K Kuchroo; Vincent Ling; Mary Collins; Arlene H Sharpe; Gordon J Freeman
Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of N Malenkovich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Yvette E Latchman; Clive R Wood; Tatyana Chernova; Divya Chaudhary; M Borde; Irina Chernova; Yoshiko Iwai; AJ Long; Julia A Brown; R Nunes; Edward Greenfield; K Bourque; Vassiliki A Boussiotis; Laura L Carter; Beatriz M Carreno; N Malenkovich; H Nishimura; T Okazaki; Tasuku Honjo; Arlene H Sharpe; Gordon J Freeman
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Nature immunology 2001;2(3):261-8.
2001: Alexander J McAdam; Rebecca J Greenwald; M A Levin; Tatyana Chernova; N Malenkovich; Vincent Ling; Gordon J Freeman; Arlene H Sharpe
ICOS is critical for CD40-mediated antibody class switching.
Nature 2001;409(6816):102-5.
2000: Alexander J McAdam; Tammy T Chang; A E Lumelsky; Edward Greenfield; Vassiliki A Boussiotis; Jonathan S Duke-Cohan; Tatyana Chernova; N Malenkovich; Claudia Jabs; Vijay K Kuchroo; Vincent Ling; Mary Collins; Arlene H Sharpe; Gordon J Freeman
Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):5035-40.
2000: Gordon J Freeman; AJ Long; Yoshiko Iwai; K Bourque; Tatyana Chernova; H Nishimura; Lori Fitz; N Malenkovich; T Okazaki; Michael C Byrne; Heidi F Horton; Lynette A Fouser; LauraL Carter; Vincent Ling; M R Bowman; Beatriz M Carreno; Mary Collins; Clive R Wood; Tasuku Honjo
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
The Journal of experimental medicine 2000;192(7):1027-34.